A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.

Paraiso MFR, Ferrando CA, Sokol ER, Rardin CR, Matthews CA, Karram MM, Iglesia CB.

Menopause. 2019 Sep 30:10.1097 .

Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.

Gambacciani M, Levancini M, Russo E, Vacca L, Simoncini T, Cervigni M.

Climacteric. 2018 Apr;21(2):148-152.

Fractional CO2 laser therapy: a new challenge for vulvovaginal atrophy in postmenopausal women.

Siliquini GP, Tuninetti V, Bounous VE, Bert F, Biglia N.

Climacteric. 2017 Aug;20(4):379-384.

Fractional CO2 Laser: From Skin Rejuvenation to Vulvo-Vaginal Reshaping.

Filippini M, Del Duca E, Negosanti F, Bonciani D, Negosanti L, Sannino M, Cannarozzo G, Nisticò SP.

Photomed Laser Surg. 2017 Mar;35(3):171-175.

Pitsouni et al.: Microablative fractional CO2-laser therapy and the genitourinary syndrome of menopause: An observational study. Maturitas. 2016 Dec;94: 131-136

An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy.

Sokol ER, Karram MM.

Menopause. 2016 Oct;23(10):1102-7.

Fractional CO2 Laser for Vulvovaginal Atrophy.

Lekskulchai O, Mairaing K, Vinayanuvattikhun N.

J Med Assoc Thai. 2016 Jul;99 Supopl 4:S54-8

Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy.

Salvatore S, Nappi RE, Parma M, Chionna R, Lagona F, Zerbinati N, Ferrero S, Origoni M, Candiani M, Leone Roberti Maggiore U.

Climacteric. 2015 Apr;18(2):219-25.

The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy.

Salvatore S, Athanasiou S, Candiani M.

Curr Opin Obstet Gynecol. 2015 Dec;27(6):504-8.

Salvatore S et al.: A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric. 2014 Aug;17(4):363-9

Microablative fractional CO2 laser improves dyspareunia related to vulvovaginal atrophy: a pilot study
J Endometr Pelvic Pain Disord 2014; 6(3): 150 – 156


Stefano Salvatore, Umberto Leone Roberti Maggiore, Massimo Origoni, Marta Parma, Lavinia Quaranta, Filomena Sileo, Alice Cola, Ilaria Baini, Simone Ferrero, Massimo Candiani, Nicola Zerbinati

Menopause. 2016 Oct;23(10):1102-7.

An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy.

Sokol ER1, Karram MM.

Fractional CO2 laser for genitourinary syndrome of menopause in breast cancer survivors: clinical, immunological, and microbiological aspects.

Becorpi A, Campisciano G, Zanotta N, Tredici Z, Guaschino S, Petraglia F, Pieralli A, Sisti G, De Seta F, Comar M.

Lasers Med Sci. 2018 Jul;33(5):1047-1054.

Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment.

Mothes AR, Runnebaum M, Runnebaum IB.

J Cancer Res Clin Oncol. 2018 May;144(5):955-960.

Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors.

Gambacciani M, Levancini M.

Menopause. 2017 Mar;24(3):316-319.

Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Are We Facing New and Safe Hopes?

Biglia N, Bounous VE, Sgro LG, D’Alonzo M, Pecchio S, Nappi RE.

Clin Breast Cancer. 2015 Dec;15(6):413-20.

J Pain. 2018 Mar;19(3):257-263. doi: 10.1016/j.jpain.2017.10.002. Epub 2017 Oct 24.

AAPT Diagnostic Criteria for Chronic Abdominal, Pelvic, and Urogenital Pain: Irritable Bowel Syndrome.

Zhou Q1, Wesselmann U2, Walker L3, Lee L4, Zeltzer L5, Verne GN6.

Phlebology. 2018 Jun;33(5):303-308. doi: 10.1177/0268355517702057. Epub 2017 Apr 5.

Sensitivity and specificity of clinical findings for the diagnosis of pelvic congestion syndrome in women with chronic pelvic pain.

Herrera-Betancourt AL1, Villegas-Echeverri JD1, López-Jaramillo JD1, López-Isanoa JD1, Estrada-Alvarez JM2.

Neural mechanisms of pelvic organ cross-sensitization.

Malykhina AP.

Neuroscience. 2007 Nov 9;149(3):660-72.

A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders.

Pezzone MA, Liang R, Fraser MO.

Gastroenterology. 2005 Jun;128(7):1953-64

Fractional CO2 laser therapy: a new challenge for vulvovaginal atrophy in postmenopausal women.

Siliquini GP, Tuninetti V, Bounous VE, Bert F, Biglia N.

Climacteric. 2017 Aug;20(4):379-384.

An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy.

Sokol ER, Karram MM.

Menopause. 2016 Oct;23(10):1102-7.

A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.

Salvatore S, Nappi RE, Zerbinati N, Calligaro A, Ferrero S, Origoni M, Candiani M, Leone Roberti Maggiore U.

Climacteric. 2014 Aug;17(4):363-9.

Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results.

Athanasiou S, Pitsouni E, Grigoriadis T, Zacharakis D, Falagas ME, Salvatore S, Protopapas A, Loutradis D.

Menopause. 2019 Mar;26(3):248-255.

Re: “Safety and long–term efficacy of fractional CO2 laser treatment in women suffering from genitourinary syndrome of menopause” [Eur. J. Obstet. Gynecol. Reprod. Biol. 213 (2017) 39-44].

Louis-Vahdat C, Gaucher S.

Eur J Obstet Gynecol Reprod Biol. 2017 Oct;217:174.

Long–term effect of thermoablative fractional CO2 laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause.

González Isaza P, Jaguszewska K, Cardona JL, Lukaszuk M.

Int Urogynecol J. 2018 Feb;29(2):211-215.

Safety and long–term efficacy of fractional CO2 laser treatment in women suffering from genitourinary syndrome of menopause.

Behnia-Willison F, Sarraf S, Miller J, Mohamadi B, Care AS, Lam A, Willison N, Behnia L, Salvatore S.

Eur J Obstet Gynecol Reprod Biol. 2017 Jun;213:39-44.

Fractional carbon dioxide laser in recalcitrant vulval lichen sclerosus.

Lee A, Lim A, Fischer G.

Australas J Dermatol. 2016 Feb;57(1):39-43.

Fractional carbon dioxide laser in recalcitrant vulvar lichen sclerosus.

Origoni M.

Australas J Dermatol. 2017 Aug;58(3):e157-e158

Lichen sclerosus et atrophicus in a surgical scar treated with fractional laser.

Mendieta-Eckert M, Ocerin-Guerra I, Landa-Gundin N.

J Cosmet Laser Ther. 2017 Apr;19(2):106-108.

Fractional CO2 laser for genitourinary syndrome of menopause in breast cancer survivors: clinical, immunological, and microbiological aspects.

Becorpi A, Campisciano G, Zanotta N, Tredici Z, Guaschino S, Petraglia F, Pieralli A, Sisti G, De Seta F, Comar M.

Lasers Med Sci. 2018 Jul;33(5):1047-1054.

Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment.

Mothes AR, Runnebaum M, Runnebaum IB.

J Cancer Res Clin Oncol. 2018 May;144(5):955-960.

Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors.

Gambacciani M, Levancini M.

Menopause. 2017 Mar;24(3):316-319.

Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Are We Facing New and Safe Hopes?

Biglia N, Bounous VE, Sgro LG, D’Alonzo M, Pecchio S, Nappi RE.

Clin Breast Cancer. 2015 Dec;15(6):413-20.